Skip to content

Apotheek Gevaert

Active
Private limited companyfounded 2009active for 16 yearsVijfseweg 134, 8790 Waregem, BelgiumKBO/BCE: BE 0820.832.410
Summary

Apotheek Gevaert has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €701,333 and a net result of €30,345. Equity is growing by about 18% per year across the filed financial years. Its solvency ranks better than 53% of 12,661 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€1.8mtotal assets 2025
Staff
0.4 FTE
Equity
€701,333
Profit
€30,345
Turnover not published (abbreviated or micro format)
Financial health
85 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Structure
Parent
Sté · 100%
  • StéDirector · permanent representative Stéphanie GEVAERT
Accounts 134 days early5 of 6 deeds read
Why 85raises risk1 change of registered office in 24 monthslowers riskFigures for financial year 2025 (filed 25-03-2026)Size: 0.4 FTE, total assets €1.8mFounded in 2009Show the evidence

Checked score

Score 2025
85 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 57% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Strong
Solvency 65-11
equity 39.5% of total assets
Liquidity 57-4
short-term debt 18.8% · cash 10.4%
Profitability 71+15
return on assets 1.7%
Bankruptcy probability, 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,222 companies, NACE 47, micro)
Last 24 months 11-2024: 0.4% 12-2024: 0.4%● unchanged vs 11-2024 01-2025: 0.4%● unchanged vs 12-2024 02-2025: 0.5%▲ +0.1 percentage points vs 01-2025 03-2025: 0.5%● unchanged vs 02-2025 04-2025: 0.6%▲ +0.1 percentage points vs 03-2025 05-2025: 0.4%▼ -0.2 percentage points vs 04-2025 06-2025: 0.4%● unchanged vs 05-2025 07-2025: 0.4%● unchanged vs 06-2025 08-2025: 1.7%▲ +1.3 percentage points vs 07-2025 09-2025: 1.7%● unchanged vs 08-2025 10-2025: 1.7%● unchanged vs 09-2025 11-2025: 1.8%▲ +0.1 percentage points vs 10-2025 12-2025: 1.8%● unchanged vs 11-2025 01-2026: 2.0%▲ +0.2 percentage points vs 12-2025highest value 02-2026: 1.9%▼ -0.1 percentage points vs 01-2026 03-2026: 1.9%● unchanged vs 02-2026 04-2026: 1.9%● unchanged vs 03-2026 05-2026: 0.3%▼ -1.6 percentage points vs 04-2026lowest value 06-2026: 0.3%● unchanged vs 05-2026lowest value 07-2026: 0.3%● unchanged vs 06-2026lowest value 08-2026: 0.3%● unchanged vs 07-2026lowest value 09-2026: 0.3%● unchanged vs 08-2026lowest value 10-2026: 0.3%● unchanged vs 09-2026lowest value
Credit of up to €55,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.99, compared with 1.89 in 2024, below 1; short-term debt: 18.8% and cash: 10.4% of total assets), and 60.5% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 55% on solvency, 64% on liquidity and 53% on profitability.

The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Figures for financial year 2025 (filed 25-03-2026)
NBB · annual accounts
lowers risk · Size: 0.4 FTE, total assets €1.8m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Founded in 2009
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-03-2026, 134 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
134 days early
2024
12 days early
2023
46 days early
2022
11 days early
2021
9 days early
2020
31 days early
2019
10 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 36 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Back to profitnet €30,345
  3. Equity above €500,000equity €701,333 ▲160%

Key points

  • Positive: Equity rose in 2025from €269,538 to €701,333 ▲ 160% View
  • Controlled by Sté 100% View
  • Positive: Filed on time since financial year 2019accounts within the deadline every year 7 years View

By topic

Financials

Financial year
2025
Total assets
€1.8m
Profit
€30,345
Solvency
39.5%
Total assets▲ 237%
Net result
20192025
Go to Financials

Timeline

Events
27
Since
2011
  1. 04-07-2025Resignation: Johan T'JOLLYN (director)
  2. 18-04-2025Annual accounts filed
  3. 29-01-2025Amendment of the articles
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
24-11-2009
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
36
Who signs
Each director alone
Annual meeting
Last Saturday of June at 18:00
Purpose
“De inrichting,uitbating en overname van apotheken en laboratoria voor…” (deed in Dutch)
Go to Articles of association

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.